| CY08E | CY09E | | Net sales | 6,693 | 8,031 | 9,637 |
| EBIDTA | 999 | 1,365 | 1,927 |
| Net profit | 775 | 723 | 1,137 |
| EPS (Rs) | 19 | 18 | 30 |
| P/E (x) | - | 26 | 15 |
| E: Analyst estimates |
| |
| The company has a target of reaching $5 billion mark by 2012 from the current $1.6 billion (2007) and will have to clock 25 per cent growth rate (current growth rate about 20 per cent) to reach there. |
| |
| With the generic business facing pricing pressures due to a competitive environment, product launches in the six-month exclusive period remain its key to rapid growth. At Rs 469, the stock discounts its FY09 earnings of Rs 30 by 15 times and should deliver healthy returns over a two year period. |
| |
